Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

CERS - CERUS CORP

IEX Last Trade
1.53
-0.040   -2.614%

Share volume: 27,298
Last Updated: Fri 27 Dec 2024 05:29:32 PM CET

PREVIOUS CLOSE
CHG
CHG%
$1.57
-0.04
-2.55%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Historical prices Events Documents Notes Dividends
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
-10.23%
3 Months
-11.24%
6 Months
-5.39%
1 Year
-29.78%
2 Year
-57.41%
Key data
Stock price
$1.53
P/E Ratio 
-17.41
DAY RANGE
$1.55 - $1.64
EPS 
-$0.13
52 WEEK RANGE
$1.61 - $2.58
52 WEEK CHANGE
-$30.09
MARKET CAP 
418.772 M
YIELD 
N/A
SHARES OUTSTANDING 
185.297 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
2.32
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,387,966
AVERAGE 30 VOLUME 
$1,135,302
Company detail
CEO: William M. Greenman
Region: US
Website: cerus.com
Employees: 290
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry:
Sector:

Cerus Corporation focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America and internationally.

Recent news